Is the Worst Over for Pfizer?

Pfizer (PFE 0.22%) celebrates its 175th anniversary this year, so the pharma giant has a long history. But the drugmaker actually jumped into the global spotlight not long ago when it launched its blockbuster coronavirus vaccine, Comirnaty, followed by top-selling COVID treatment Paxlovid. These two products helped Pfizer reach a record $100 billion in annual revenue in 2022.The past year, though, has been a difficult one for the big pharma company. Demand for coronavirus products has been on the decline, w ...